Later Annals of Natal
In: Journal of the Royal African Society, Band XXXVIII, Heft CL, S. 193-194
ISSN: 1468-2621
10 Ergebnisse
Sortierung:
In: Journal of the Royal African Society, Band XXXVIII, Heft CL, S. 193-194
ISSN: 1468-2621
In: Journal of the Royal African Society, Band XXXVII, Heft CXLVII, S. 259-259
ISSN: 1468-2621
In: Journal of the Royal African Society, Band XXXVI, Heft CXLIII, S. 243-243
ISSN: 1468-2621
In: Journal of the Royal African Society, Band XXXVI, Heft CXLIII, S. 243-244
ISSN: 1468-2621
In: Journal of the Royal African Society, Band XXXVI, Heft CXLII, S. 119-119
ISSN: 1468-2621
In: Journal of the Royal African Society, Band XXXV, Heft CXLI, S. 459-460
ISSN: 1468-2621
In: Journal of the Royal United Services Institute for Defence Studies, Band 122, Heft 2, S. 35-39
ISSN: 1744-0378
In: Handbook of Science and Technology Convergence, S. 933-955
In: Handbook of Science and Technology Convergence, S. 1119-1139
INTRODUCTION: The Department of Defense (DoD) and the Department of Veterans Affairs (VA) provide comprehensive HIV treatment and care to their beneficiaries with open access and few costs to the patient. Individuals who receive HIV care in the VA have higher rates of substance abuse, homelessness and unemployment than individuals who receive HIV care in the DoD. A comparison between individuals receiving HIV treatment and care from the DoD and the VA provides an opportunity to explore the impact of individual-level characteristics on clinical outcomes within two healthcare systems that are optimized for clinic retention and medication adherence. METHODS: Data were collected on 1065 patients from the HIV Atlanta VA Cohort Study (HAVACS) and 1199 patients from the US Military HIV Natural History Study (NHS). Patients were eligible if they had an HIV diagnosis and began HAART between January 1, 1996 and June 30, 2010. The analysis examined the survival from HAART initiation to all-cause mortality or an AIDS event. RESULTS: Although there was substantial between-cohort heterogeneity and the 12-year survival of participants in NHS was significantly higher than in HAVACS in crude analyses, this survival disparity was reduced from 21.5% to 1.6% (mortality only) and 26.8% to 4.1% (combined mortality or AIDS) when controlling for clinical and demographic variables. CONCLUSION: We assessed the clinical outcomes for individuals with HIV from two very similar government-sponsored healthcare systems that reduced or eliminated many barriers associated with accessing treatment and care. After controlling for clinical and demographic variables, both 12-year survival and AIDS-free survival rates were similar for the two study cohorts who have open access to care and medication despite dramatic differences in socioeconomic and behavioral characteristics.
BASE